CSS
GSK icon

Cubist Systematic Strategies’s GSK GSK Stock Holding History

Cubist Systematic Strategies’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-64,500
Closed -$2.39M – 3932
2023
Q4 		$2.39M Hold
64,500
– – 0.02% 1387
2023
Q3 		$2.34M Hold
64,500
– – 0.02% 1258
2023
Q2 		$2.3M Sell
64,500
-22,500
-26% -$807K 0.02% 1374
2023
Q1 		$3.1M Sell
87,000
-34,800
-29% -$1.22M 0.02% 1318
2022
Q4 		$4.28M Buy
121,800
+22,200
+22% +$739K 0.03% 1154
2022
Q3 		$2.93M Buy
+99,600
New +$3.77M 0.02% 1615

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Cubist Systematic Strategies's GSK Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of GSK (GSK) in Q2 2024, closing a stake of 22,931 shares — an estimated $983K sold.

Cubist Systematic Strategies first reported a position in GSK in Q2 2014 and held it in 38 quarters. The position peaked at $28.8M in Q3 2022. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 22,931 GSK shares in Q2 2024, an estimated $983K.
  • Cubist Systematic Strategies first reported a position in GSK in Q2 2014 and held it in 38 quarters.
  • Cubist Systematic Strategies's GSK position peaked at $28.8M in Q3 2022.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.